Documented Case Studies

Real Patients.
Documented Outcomes.

Twelve condition-specific case studies from MindScape Retreat — the protocol, the measurements, and the outcome for each. Details are anonymized to protect privacy; individual results vary.

91.7%success rate

Opioid & Fentanyl Addiction

Detox and sustained recovery from opioids and fentanyl, with the withdrawal window compressed to days.

Read the case study →

98.6%PCL-5 resolution

PTSD & Trauma

Trauma resolution measured on the PCL-5 at follow-up across a veteran-heavy cohort.

Read the case study →

C-PTSDdocumented protocol

Complex PTSD

Layered developmental trauma addressed with a staged ibogaine protocol and structured integration.

Read the case study →

90%abstinence rate

Alcohol Dependency

Craving interruption and abstinence outcomes for long-term alcohol dependence.

Read the case study →

89%medication-free

Methadone & Suboxone

Coming off long-half-life maintenance medications — the hardest detox in addiction medicine.

Read the case study →

92%recovery at 90 days

Kratom Addiction

Kratom dependence resolved with documented 90-day follow-up outcomes.

Read the case study →

98.67%improvement

Anxiety

Severe anxiety measured before and after treatment on standardized scales.

Read the case study →

3-in-1co-occurring case

Depression, OCD & TBI

A complex co-occurring presentation — depression, OCD, and traumatic brain injury — in one documented journey.

Read the case study →

Documentedrecovery protocol

Stimulant & Cocaine

Stimulant addiction addressed through dopamine-pathway reset and structured aftercare.

Read the case study →

62%motor improvement · 100 patients

Parkinson's Disease

The largest known ibogaine Parkinson's dataset — UPDRS-measured motor outcomes.

Read the case study →

30patient case series

Multiple Sclerosis

A 30-patient MS case series alongside the GDNF neurotrophic research base.

Read the case study →

88%success rate

SSRI Discontinuation

Medication-free transitions off SSRIs with medically supervised tapering support.

Read the case study →

Each figure above is drawn from the linked case study, where cohort size, measurement scales, and methodology are documented. Case details are anonymized composites where noted on the study page.

See the aggregate picture

Case studies show individual journeys. Our outcomes page shows the aggregate data across 1,000+ patients — and your own journey starts with a confidential pre-screen.

View Treatment Outcomes Begin Your Confidential Pre-Screen

Real Patients.Documented Outcomes.

See the aggregate picture

Real Patients.
Documented Outcomes.